From: Variation of PD-L1 expression in locally advanced cervical cancer following neoadjuvant chemotherapy
Age | FIGO stage | Histological grade | Clinical response | Lymph node metastasis | HPV status | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 40 | ≥40 | Ib2 | IIa2 | I-II | III | CR | Non-CR | Yes | No | + | _ | |
PD-L1 before NAC | ||||||||||||
Low | 16 | 80 | 68 | 28 | 80 | 16 | 71 | 25 | 9 | 87 | 36 | 3 |
High | 15 | 31 | 28 | 18 | 35 | 11 | 37 | 9 | 5 | 41 | 75 | 3 |
p value (χ2) | 0.031 (4.631) | 0.235 (1.410) | 0.303 (1.060) | 0.397 (0.716) | 0.780 (0.078) | 0.374 (0.791) | ||||||
PD-L1 after NAC | ||||||||||||
Low | 18 | 58 | 52 | 24 | 62 | 14 | 61 | 15 | 5 | 71 | 63 | 4 |
High | 13 | 53 | 44 | 22 | 53 | 13 | 47 | 19 | 9 | 57 | 48 | 2 |
p value (χ2) | 0.566 (0.329) | 0.824 (0.050) | 0.847 (0.037) | 0.207 (1.589) | 0.159 (1.980) | 0.633 (0.228) | ||||||
PD-L1 change | ||||||||||||
increase/stable | 20 | 85 | 73 | 32 | 87 | 18 | 74 | 31 | 12 | 93 | 80 | 3 |
decrease | 11 | 26 | 23 | 14 | 28 | 9 | 34 | 3 | 2 | 35 | 31 | 3 |
p value (χ2) | 0.176 (1.829) | 0.411 (0.677) | 0.338 (0.916) | 0.009 (6.890) | 0.291 (1.117) | 0.246 (1.345) |